The global antibody-mediated rejection prevention market is predicted to reach a valuation of US$ 89 million in 2023, with a compound annual growth rate (CAGR) of 16%, as per a recently published FMI report. Over the last decade, the complement system has emerged as an important constituent of the AMR market. Technological innovations, such as genomic research and …
Monthly Archives: March 2023
Uterine Manipulation Devices Market accounted for an absolute dollar opportunity of nearly US$ 255.2 Million from 2023 to 2033
The Uterine Manipulation Devices market revenues were estimated at US$ 297.7 Million in 2022 and is anticipated to grow at a CAGR of 6.1% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 570.3 Million. The aggregate revenue from the US, …
Eye Tracking System Market is expected to reach US$ 4.9 Billion by 2028, at a CAGR 26.6%
Eye Tracking System Market valuation of US$ 4.9 Billion by 2028, rapidly expanding at a CAGR of 26.6% from 2022 to 2028. Eye-tracking systems are therefore a key amalgamation of software and hardware which allows allowing retailers, automotive OEMs and researchers to assess and track the eye movements of the person to assess behaviour and movements. Consumer preference and safety …
Orthokeratology Market is projected to rise at a 7.3% CAGR through 2028
The global orthokeratology market is expected to reach a valuation of US$ 88.7 Million in 2028, with sales growing at a robust CAGR of 7.3% over the forecast period of 2022 to 2028. Climbing up from a value of US$ 58.1 Million in 2022, the orthokeratology market is driven by the eradication of contact lens-related vision problems. …
Continue reading “Orthokeratology Market is projected to rise at a 7.3% CAGR through 2028”
Healthcare Regulatory Affairs Outsourcing Market at a CAGR of 11.3% during the period 2023 to 2033
The healthcare regulatory affairs outsourcing market size is expected to reach a valuation of US$ 5.8 Billion by 2033. As of 2023, the market is valued at US$ 2 Billion, and is expected to grow at a CAGR of 11.3% during the forecast period. The surging number of cases pertaining to chronic ailments and increased …
Clinical Alarm Management Market is expected to surpass US$ 6.2 billion by 2033 at a CAGR 7.5%
The clinical alarm management market is expected to reach US$ 6.2 billion by 2033, recording a 7.5% CAGR during the forecast period (2023 to 2033). Alarms alert personnel when a situation is dangerous or life-threatening and requires immediate attention; nevertheless, they regularly sound even when no such scenario exists. Most non-urgent alarms do not require …
Lab Automation Market is expected to surpass US$ 5.5 billion by 2033, at a CAGR 10.1%
During the forecast period, the lab automation market is expected to register a CAGR of 10.1%. The market is anticipated to grow from a valuation of USD 2.1 billion in 2023 to USD 5.5 billion by 2033. Research and Innovations Aid Market Growth The market is secured by steady demand for pharmaceutical research. In addition, …
Sports Medicine Market is expected to reach US$ 11.4 Billion by 2032
In 2022, the worldwide sports medicine market is anticipated to be worth US$ 6.8 billion. Growing at a 5.3% CAGR, it will reach US$ 11.4 billion by 2032. According to the analysis, body reconstruction products would command a market share of approximately 81.3% in 2021. Sports medicine is a rapidly expanding healthcare specialty because the …
Continue reading “Sports Medicine Market is expected to reach US$ 11.4 Billion by 2032”
Continuous Renal Replacement Therapy Market is likely to grow at a CAGR of 7.7% through 2027
The global Continuous Renal Replacement Therapy market was worth US$ 1 Billion in the year 2021 and is poised to reach US$ 1.68 Billion by the year 2027 at a CAGR of 7.7% between 2021 and 2027. Continuous Renal Replacement Therapy is inclusive of removal of solute from the blood through hemofiltration or hemodialysis or …
Pelvic Cancer Induced Hemorrhegic Cystitis Market to expand at an 18.01% value CAGR by 2033
According to Future Market Insights, the global pelvic cancer induced hemorrhagic cystitis market size is estimated to achieve an amazing valuation of US$ 2.1 billion in 2023 and reach US$ 11 billion by 2033, at a CAGR of 18.01%. Rising awareness among the population regarding early treatment and diagnosis for related disorders, coupled with the …